Effects of Dietary Self-Monitoring, Physical Activity, Liraglutide 3.0 mg, and Placebo on Weight Loss in the SCALE IBT Trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Effects of Dietary Self-Monitoring, Physical Activity, Liraglutide 3.0 mg, and Placebo on Weight Loss in the SCALE IBT Trial ; volume:13 ; number:6 ; year:2020 ; pages:572-583
Obesity facts ; 13, Heft 6 (2020), 572-583
- Creator
-
Tronieri, Jena S.
Fabricatore, Anthony N.
Wadden, Thomas A.
Auerbach, Pernille
Endahl, Lars
Sugimoto, Danny
Rubino, Domenica
- DOI
-
10.1159/000511130
- URN
-
urn:nbn:de:101:1-2020122323343483789047
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tronieri, Jena S.
- Fabricatore, Anthony N.
- Wadden, Thomas A.
- Auerbach, Pernille
- Endahl, Lars
- Sugimoto, Danny
- Rubino, Domenica
Other Objects (12)
Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic Analysis
Self-monitoring and corporate interests
Effect of preoperative liraglutide 3.0 mg on incidence of intraoperative adhesions in laparoscopic sleeve gastrectomy
Use of Liraglutide 3.0 mg for Weight Management in a Real-World Setting in Switzerland
Mentoring network and self-monitoring personality
Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial
Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials
Self-monitoring for maintenance of vehicle fleets
Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery
Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Liraglutide 1.8 mg: A Health Economic Analysis in the UK
Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial
Correction to: Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial
Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic Analysis
Self-monitoring and corporate interests
Effect of preoperative liraglutide 3.0 mg on incidence of intraoperative adhesions in laparoscopic sleeve gastrectomy
Use of Liraglutide 3.0 mg for Weight Management in a Real-World Setting in Switzerland
Mentoring network and self-monitoring personality
Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial
Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials
Self-monitoring for maintenance of vehicle fleets
Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery
Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Liraglutide 1.8 mg: A Health Economic Analysis in the UK
Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial
Correction to: Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial
Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic Analysis
Self-monitoring and corporate interests
Effect of preoperative liraglutide 3.0 mg on incidence of intraoperative adhesions in laparoscopic sleeve gastrectomy
Use of Liraglutide 3.0 mg for Weight Management in a Real-World Setting in Switzerland
Mentoring network and self-monitoring personality
Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial
Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials
Self-monitoring for maintenance of vehicle fleets
Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery
Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Liraglutide 1.8 mg: A Health Economic Analysis in the UK
Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial